JP2023538260A5 - - Google Patents
Info
- Publication number
- JP2023538260A5 JP2023538260A5 JP2023507600A JP2023507600A JP2023538260A5 JP 2023538260 A5 JP2023538260 A5 JP 2023538260A5 JP 2023507600 A JP2023507600 A JP 2023507600A JP 2023507600 A JP2023507600 A JP 2023507600A JP 2023538260 A5 JP2023538260 A5 JP 2023538260A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- nanoparticles
- approximately
- mol
- nanoparticle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062367P | 2020-08-06 | 2020-08-06 | |
| US63/062,367 | 2020-08-06 | ||
| PCT/US2021/045038 WO2022032154A2 (en) | 2020-08-06 | 2021-08-06 | Compositions for the delivery of payload molecules to airway epithelium |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538260A JP2023538260A (ja) | 2023-09-07 |
| JP2023538260A5 true JP2023538260A5 (cg-RX-API-DMAC7.html) | 2024-08-15 |
| JP7877291B2 JP7877291B2 (ja) | 2026-06-22 |
Family
ID=77543659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507600A Active JP7877291B2 (ja) | 2020-08-06 | 2021-08-06 | ペイロード分子を気道上皮に送達するための組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230285310A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4192433A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7877291B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230087443A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116348147A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021320426A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023001955A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3189854A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300111A (cg-RX-API-DMAC7.html) |
| MA (1) | MA71659A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001461A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202214215A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022032154A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20220070T1 (hr) | 2014-04-23 | 2022-04-01 | Modernatx, Inc. | Cjepiva nukleinske kiseline |
| EP3328394A4 (en) | 2015-07-30 | 2019-03-13 | ModernaTX, Inc. | CONCATEMEE peptide epitope RNAs |
| EP3364949A4 (en) | 2015-10-22 | 2019-07-31 | ModernaTX, Inc. | CANCER VACCINES |
| DE20164728T1 (de) | 2015-10-22 | 2021-09-30 | Modernatx, Inc. | Impfstoffe gegen atemwegsvirus |
| SG11201901941YA (en) | 2016-09-14 | 2019-04-29 | Modernatx Inc | High purity rna compositions and methods for preparation thereof |
| MA46766A (fr) | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| WO2018170270A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Varicella zoster virus (vzv) vaccine |
| MA48047A (fr) | 2017-04-05 | 2020-02-12 | Modernatx Inc | Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée |
| WO2019036682A1 (en) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | RNA VARIANTS POLYMERASE |
| WO2019036685A1 (en) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | METHODS FOR HPLC ANALYSIS |
| US11911453B2 (en) | 2018-01-29 | 2024-02-27 | Modernatx, Inc. | RSV RNA vaccines |
| US12151029B2 (en) | 2018-09-19 | 2024-11-26 | Modernatx, Inc. | PEG lipids and uses thereof |
| CN112996854B (zh) | 2018-09-19 | 2024-08-30 | 摩登纳特斯有限公司 | 高纯度peg脂质和其用途 |
| DK3864163T3 (da) | 2018-10-09 | 2024-05-06 | Univ British Columbia | Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed |
| MX2021011031A (es) | 2019-03-11 | 2021-12-10 | Modernatx Inc | Proceso de transcripción in vitro en lotes alimentados. |
| MA55321A (fr) | 2019-03-15 | 2022-01-19 | Modernatx Inc | Vaccins à base d'arn contre le vih |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| WO2022150717A1 (en) | 2021-01-11 | 2022-07-14 | Modernatx, Inc. | Seasonal rna influenza virus vaccines |
| MX2023011227A (es) | 2021-03-22 | 2023-12-06 | Recode Therapeutics Inc | Composiciones y metodos para administracion dirigida a celulas. |
| MX2023011243A (es) | 2021-03-23 | 2023-12-14 | Recode Therapeutics Inc | Composiciones de polinucleotidos, formulaciones relacionadas y metodos de uso de los mismos. |
| US20220363937A1 (en) | 2021-05-14 | 2022-11-17 | Armstrong World Industries, Inc. | Stabilization of antimicrobial coatings |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| US20260109732A1 (en) * | 2021-10-29 | 2026-04-23 | Modernatx, Inc. | Lipid amines |
| WO2023076605A1 (en) * | 2021-10-29 | 2023-05-04 | Modernatx, Inc. | Lipid amines |
| EP4429644A1 (en) * | 2021-11-12 | 2024-09-18 | ModernaTX, Inc. | Compositions for the delivery of payload molecules to airway epithelium |
| TW202345863A (zh) | 2022-02-09 | 2023-12-01 | 美商現代公司 | 黏膜投與方法及調配物 |
| EP4479082A4 (en) * | 2022-02-15 | 2026-06-10 | Broad Inst Inc | CELL-TYPE SPECIFIC TARGETING CONTRACTILE INJECTION SYSTEM |
| US20250188028A1 (en) * | 2022-03-14 | 2025-06-12 | Nanovation Therapeutics Inc. | Synthetic Method for Producing Ionizable Amino Lipids |
| WO2023198085A1 (zh) * | 2022-04-12 | 2023-10-19 | 厦门赛诺邦格生物科技股份有限公司 | 一种含有叔胺的氮支化非线性聚乙二醇化脂质及其应用 |
| CN117003808B (zh) * | 2022-04-28 | 2026-05-29 | 北京科兴中维生物技术有限公司 | 一种阳离子脂质化合物及其制备方法和用途 |
| CN117243922A (zh) | 2022-04-29 | 2023-12-19 | 北京剂泰医药科技有限公司 | 脂质纳米颗粒 |
| CN119816292A (zh) * | 2022-08-08 | 2025-04-11 | 先进核糖核酸疫苗(Arv)技术股份有限公司 | 基于甾醇的可电离脂质以及包含其的脂质纳米颗粒 |
| CN120153078A (zh) | 2022-10-27 | 2025-06-13 | 辉瑞大药厂 | 编码rsv-f的rna分子及含所述rna分子的疫苗 |
| IL320338A (en) | 2022-11-04 | 2025-06-01 | Pfizer | Fatty compounds and their uses |
| IL321026A (en) | 2022-12-08 | 2025-07-01 | Recode Therapeutics Inc | Nanoparticle formulations and their uses |
| EP4637825A4 (en) * | 2022-12-19 | 2026-04-22 | Fujifilm Corp | METHODS OF ADMINISTRATION OF THERAPEUTIC AGENTS AND LIPID COMPOSITIONS |
| WO2024161249A1 (en) | 2023-01-31 | 2024-08-08 | Pfizer Inc. | Lipid compounds and uses thereof |
| US20240293318A1 (en) * | 2023-02-13 | 2024-09-05 | Flagship Pioneering Innovations Vii, Llc | Cleavable linker-containing ionizable lipids and lipid carriers for therapeutic compositions |
| EP4694871A1 (en) * | 2023-04-14 | 2026-02-18 | Beijing Jitai Pharmaceutical Technology Co., Ltd. | Lipid nanoparticle compositions and uses thereof |
| EP4704905A1 (en) * | 2023-05-02 | 2026-03-11 | Sage Therapeutics, LLC | Lymphatic system-targeting compounds |
| EP4704816A1 (en) * | 2023-05-03 | 2026-03-11 | ModernaTX, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
| CN119143620A (zh) | 2023-06-16 | 2024-12-17 | 北京剂泰医药科技有限公司 | 一种快速代谢的脂质化合物 |
| WO2025027492A1 (en) | 2023-07-31 | 2025-02-06 | Pfizer Inc. | Coronavirus antigen variants |
| EP4758123A1 (en) * | 2023-08-07 | 2026-06-17 | Life Technologies Corporation | Lipids for delivery of nucleic acids to eukaryotic cells |
| US12364773B2 (en) | 2023-12-01 | 2025-07-22 | Recode Therapeutics, Inc. | Lipid nanoparticle compositions and uses thereof |
| WO2025126019A1 (en) | 2023-12-13 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| WO2025126071A1 (en) | 2023-12-14 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| WO2025126118A1 (en) | 2023-12-15 | 2025-06-19 | Pfizer Inc. | Lipid compounds and uses thereof |
| WO2025126113A1 (en) | 2023-12-15 | 2025-06-19 | Pfizer Inc. | Lipid compounds and uses thereof |
| CN117919200B (zh) * | 2024-01-19 | 2025-09-05 | 晟迪生物医药(苏州)有限公司 | 含有可电离脂质的肺部递送系统、其制备方法和应用 |
| WO2025180480A1 (zh) * | 2024-03-01 | 2025-09-04 | 北京剂泰医药科技有限公司 | 靶向肌肉的脂质纳米颗粒 |
| WO2025186725A2 (en) | 2024-03-06 | 2025-09-12 | Pfizer Inc. | Improved lnp formulations and uses thereof |
| WO2025207803A1 (en) * | 2024-03-26 | 2025-10-02 | General Therapeutics, Inc. | Lipid compounds, compositions and methods of use thereof |
| CN120718086B (zh) * | 2024-06-13 | 2026-06-26 | 仁景(苏州)生物科技有限公司 | 用于递送的脂质化合物和脂质纳米颗粒 |
| WO2026018181A1 (en) | 2024-07-17 | 2026-01-22 | Pfizer Inc. | Immunogenic compositions and uses thereof |
| WO2026029597A1 (ko) * | 2024-07-31 | 2026-02-05 | 주식회사 메디치바이오 | 신규한 스테롤 지질 또는 이의 유도체를 함유하는 지질 나노입자 조성물 |
| WO2026030275A1 (en) | 2024-08-01 | 2026-02-05 | Pfizer Inc. | Rna molecules |
| WO2026088119A1 (en) | 2024-10-24 | 2026-04-30 | Pfizer Inc. | Lipidated tlr7/8 modulators as adjuvants and uses thereof |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681702A (en) | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
| US5840710A (en) * | 1994-12-09 | 1998-11-24 | Genzyme Corporation | Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| US5925628A (en) * | 1997-03-31 | 1999-07-20 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| US5942634A (en) * | 1997-05-09 | 1999-08-24 | Genzyme Corporation | Cationic amphiphiles for cell transfections |
| US20030073640A1 (en) | 1997-07-23 | 2003-04-17 | Ribozyme Pharmaceuticals, Inc. | Novel compositions for the delivery of negatively charged molecules |
| US7404969B2 (en) | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| CA2597724A1 (en) | 2005-02-14 | 2007-08-02 | Sirna Therapeutics, Inc. | Cationic lipids and formulated molecular compositions containing them |
| WO2008103276A2 (en) | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| EP2217221B1 (en) * | 2007-10-17 | 2018-06-27 | Korea Advanced Institute of Science and Technology | Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same |
| WO2010021865A1 (en) | 2008-08-18 | 2010-02-25 | Merck Sharp & Dohme Corp. | Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| WO2010080724A1 (en) | 2009-01-12 | 2010-07-15 | Merck Sharp & Dohme Corp. | Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| ES2613498T3 (es) | 2009-07-01 | 2017-05-24 | Protiva Biotherapeutics Inc. | Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos |
| US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| US9181295B2 (en) | 2009-08-20 | 2015-11-10 | Sirna Therapeutics, Inc. | Cationic lipids with various head groups for oligonucleotide delivery |
| US20120253032A1 (en) | 2009-10-08 | 2012-10-04 | Merck Sharp & Dohme Corporation | Novel cationic lipids with short lipid chains for oligonucleotide delivery |
| SI2506857T1 (en) | 2009-12-01 | 2018-08-31 | Translate Bio, Inc. | Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases |
| US20130116419A1 (en) | 2010-01-22 | 2013-05-09 | Daniel Zewge | Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry |
| WO2011143230A1 (en) | 2010-05-10 | 2011-11-17 | Alnylam Pharmaceuticals | Methods and compositions for delivery of active agents |
| US20130123338A1 (en) | 2010-05-12 | 2013-05-16 | Protiva Biotherapeutics, Inc. | Novel cationic lipids and methods of use thereof |
| WO2011149733A2 (en) | 2010-05-24 | 2011-12-01 | Merck Sharp & Dohme Corp. | Novel amino alcohol cationic lipids for oligonucleotide delivery |
| DK2575767T3 (en) | 2010-06-04 | 2017-03-13 | Sirna Therapeutics Inc | HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES |
| US8466122B2 (en) | 2010-09-17 | 2013-06-18 | Protiva Biotherapeutics, Inc. | Trialkyl cationic lipids and methods of use thereof |
| ES2987915T3 (es) | 2010-09-20 | 2024-11-18 | Sirna Therapeutics Inc | Nuevos lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos |
| EP2621480B1 (en) | 2010-09-30 | 2018-08-15 | Sirna Therapeutics, Inc. | Low molecular weight cationic lipids for oligonucleotide delivery |
| EP2857499A1 (en) | 2010-10-01 | 2015-04-08 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| WO2012054365A2 (en) | 2010-10-21 | 2012-04-26 | Merck Sharp & Dohme Corp. | Novel low molecular weight cationic lipids for oligonucleotide delivery |
| DK2635265T3 (en) | 2010-11-05 | 2018-07-16 | Sirna Therapeutics Inc | New low molecular weight cyclic amine-containing cationic lipids for oligonucleotide delivery |
| US9999673B2 (en) | 2011-01-11 | 2018-06-19 | Alnylam Pharmaceuticals, Inc. | PEGylated lipids and their use for drug delivery |
| EP4074693A1 (en) | 2011-06-08 | 2022-10-19 | Translate Bio, Inc. | Cleavable lipids |
| US9126966B2 (en) | 2011-08-31 | 2015-09-08 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods of use thereof |
| DE21212055T1 (de) | 2011-12-07 | 2022-08-04 | Alnylam Pharmaceuticals, Inc. | Biologisch abbaubare lipide zur freisetzung von wirkstoffen |
| US20140308304A1 (en) | 2011-12-07 | 2014-10-16 | Alnylam Pharmaceuticals, Inc. | Lipids for the delivery of active agents |
| WO2013103659A1 (en) | 2012-01-04 | 2013-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus |
| WO2013116126A1 (en) | 2012-02-01 | 2013-08-08 | Merck Sharp & Dohme Corp. | Novel low molecular weight, biodegradable cationic lipids for oligonucleotide delivery |
| US9352042B2 (en) | 2012-02-24 | 2016-05-31 | Protiva Biotherapeutics, Inc. | Trialkyl cationic lipids and methods of use thereof |
| WO2014093924A1 (en) | 2012-12-13 | 2014-06-19 | Moderna Therapeutics, Inc. | Modified nucleic acid molecules and uses thereof |
| KR20140048404A (ko) * | 2012-10-11 | 2014-04-24 | 포항공과대학교 산학협력단 | 저밀도 지단백질 유사 나노입자 및 이를 포함하는 간 표적 진단 및 치료용 조성물 |
| PT2922554T (pt) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Arn modificado nas porções terminais |
| WO2014164253A1 (en) | 2013-03-09 | 2014-10-09 | Moderna Therapeutics, Inc. | Heterologous untranslated regions for mrna |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| CN105143456A (zh) | 2013-03-15 | 2015-12-09 | 不列颠哥伦比亚大学 | 用于转染的脂质纳米粒子和相关方法 |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| JP7332478B2 (ja) * | 2017-03-15 | 2023-08-23 | モデルナティエックス インコーポレイテッド | 脂質ナノ粒子製剤 |
| RS63953B1 (sr) * | 2017-03-15 | 2023-02-28 | Modernatx Inc | Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava |
| US11529314B2 (en) * | 2017-11-10 | 2022-12-20 | Board Of Regents, The University Of Texas System | Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
-
2021
- 2021-08-06 WO PCT/US2021/045038 patent/WO2022032154A2/en not_active Ceased
- 2021-08-06 BR BR112023001955A patent/BR112023001955A2/pt not_active Application Discontinuation
- 2021-08-06 US US18/040,485 patent/US20230285310A1/en active Pending
- 2021-08-06 CN CN202180068470.XA patent/CN116348147A/zh active Pending
- 2021-08-06 CA CA3189854A patent/CA3189854A1/en active Pending
- 2021-08-06 TW TW110129202A patent/TW202214215A/zh unknown
- 2021-08-06 AU AU2021320426A patent/AU2021320426A1/en not_active Abandoned
- 2021-08-06 IL IL300111A patent/IL300111A/en unknown
- 2021-08-06 EP EP21762908.8A patent/EP4192433A2/en active Pending
- 2021-08-06 JP JP2023507600A patent/JP7877291B2/ja active Active
- 2021-08-06 MX MX2023001461A patent/MX2023001461A/es unknown
- 2021-08-06 KR KR1020237007762A patent/KR20230087443A/ko not_active Withdrawn
- 2021-08-06 MA MA71659A patent/MA71659A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024545584A5 (cg-RX-API-DMAC7.html) | ||
| CN118319880B (zh) | 靶向肺部高效递送核酸的脂质纳米颗粒、吸入式制剂及应用 | |
| US10081598B2 (en) | Cationic lipid | |
| CA2737025C (en) | Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof | |
| JP2024527940A5 (cg-RX-API-DMAC7.html) | ||
| US6124270A (en) | Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug | |
| KR101476167B1 (ko) | 약물 송달 제어용 경폐 투여 리포좀 | |
| US9233971B2 (en) | Lipomacrocycles and uses thereof | |
| US20250051263A1 (en) | Novel ionizable lipids and lipid nanoparticles and methods of using the same | |
| JP2023538260A (ja) | ペイロード分子を気道上皮に送達するための組成物 | |
| JP7708388B2 (ja) | 荷電物質を送達する脂質、その製剤、およびその製造方法 | |
| CN107260679B (zh) | 用以减少眼用类固醇的并发症的药物组合物 | |
| JP2023518944A5 (cg-RX-API-DMAC7.html) | ||
| JP7832717B2 (ja) | 硫化物を含むイオン化可能な脂質、及びこれを含む脂質ナノ粒子 | |
| WO2024017254A1 (zh) | 氨基脂质化合物、其制备方法和应用 | |
| JP2024545584A (ja) | ペイロード分子を気道上皮に送達するための組成物 | |
| WO2024019770A1 (en) | Methods of making ionizable lipids and lipid nanoparticles for mrna delivery | |
| WO2024094194A1 (zh) | 一种用于雾化吸入脂质纳米粒的通用型处方 | |
| WO2023246218A1 (zh) | 用于核酸递送的可电离脂质及其组合物 | |
| EP4628496A1 (en) | Steroid-cationic lipid compound and use thereof | |
| CN117946201B (zh) | 脂质化合物和脂质纳米颗粒组合物 | |
| TW202530174A (zh) | 用於遞送的脂質化合物及脂質奈米顆粒 | |
| EP4626858A1 (en) | Novel ionizable lipids and lipid nanoparticles comprising the same | |
| US20250281419A1 (en) | Lipid amines | |
| CN116157117A (zh) | 磷脂 |